Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
ABSOLUTELY ... people have short memories !!!
The science is amazing. The company is in an amazing place yet the comms is a joke always here. People have to guess what is happening. This is worse than an AIM stock. I strongly believe the wording stating trials expected to start in 2023 was a pump again and there to create a buying frenzy. How can they state that and not have funding in place or maybe they had funding and then vlad messed it up and lost the partner they had ... like in the Eli lilly days
Personally, this is a great price to buy but needs serious patience and hope. I wish the company would be bought and we get a real commercially focused ceo and the value of the company is realised. This will continue to hobble at this low price until people start to trust vlad or his RNSs !!!
We all know that stocks are not bought by peoples views on here. If they are, well thats their issue. I am just a bit bored and a bit anxious thats all. Mickey is the same. There are many. I don't believe the 2 RNS on CBR were more than a pump that failed to return the results sadly. Yes the content was amazing but I feel it was just a way of raising the share price which didnt happen
Anyways, I know I can sell or just wait or shut up but the point being here is that this stock is purely governed by sentiment and we had really momentum after the FDA announcement. Now its all gone and we are in this phase of not knowing what is happening ... good or bad behind the scene. This will just move between 2.85 and 3 as traders make their few percent and we just have to suck it up ...
We are all now in an interesting position. We all have to make a decision on whether this quiet period means news will be huge or will not be. Personally I have nowhere to go having been here for a long time but am shocked at the silence AGAIN. Yes i know we need to patient or sell but everytime we have great upside, its totally destroyed by times of silence and people having to guess what will be next. It really hasn't learnt that real comms is all shareholders want !!!!
Dhub ... I think the scientific gift that hemo can bring to the market is amazing but i am not confident that the RNSs they announce are genuine sometimes. I think now they have ulterior motives and are mainly aimed at pumping the stock
- The RNS from Nov 2023 stated clearly they "expected" to have trials in 2023. There was no chance of that and I highlighted it. If that was the case then, what is taking so long now. I hope it is plans have changed and it is bigger than before
- They announced 2 CBR RNSs back to back when they needed to rise the share price. It didnt work since people have been burnt in the past and were then expecting a placing. It didnt happen but people didnt buy
- The prevail investment was so small in the grand scheme of things. I now think by stating 6p they thought people would pump it to 6p. They didnt ...
There are many examples of the last 5 years where pumping has worked in the covid days and then got shafted by mint financing. Sadly this is really tough on shareholders and great for shorters and traders. They are just taking advantage sadly of the bad decisions and trust that no one has in Vlad and hemo.
For every buy there is a matched sell dropping the price down again !!! This is becoming a bit predictable sadly and the shorters have full control of the situation and could have until we hear news. Strange that people were buying at 4.3p in Jan 2023 and now we have FDA approval, they cant even invest at 3p .... wierd stock this
The only way we will get a rise and it will stay high is when the number of LTHs and institutions are in the majority and the shorters and traders are not. This has always been the case with hemo and in theory it could be justified by the bad decisions vlad has made in the past.
I do agree though there is absolutely no guarantee even with funding this has a massive rise even it should and this again is because lack of trust, visibility and understanding of this stock. The only reason I still stay here is because of Haywain and JHFH who give me hope that if they are staying, so should I.
I think no news on Placing rules that out. This will stay around this level until shorters leave or RNS comes ... rumours or predictions on these boards are useless as even pumps don't work here since volume is so small.
All those that predicted FDA would not lift the CH were surprised when it did and even though it didnt make a dent on the share price, it provided Hemo are good to go. I cannot believe that the HEMO CART product would be less interesting to big pharma so this could only mean the partnership or licencing is bigger than expected and is taking longer than expected. The day that news arrives, we can all just start to enjoy the hemo journey again!!!
Sprint ... not true. We got 2 amazing updates on CBR but the desired effect of getting a super pump was not relealised.
Remember vlad stated many times he doesn't care for investors and so he will not care what the share price is ... All we can hope is that this time is being spent finalising a mega deal !!!! Its always hope with hemo and never an easy ride and happy for investors.
Someone who needs the money and is bored of waiting for an update ... its always the case with hemo. They release amazing news and then miss out on the big real rerate with news delays. Just gotta wait and hope !!!!
Haywain ... Your analysis and write ups give every holder of Hemo shares a real boost that we are holding onto something special here. The shorters must hate your truly positive but accurate reflection of the science and also where we are with Hemo. It is crazy that the buyers are still waiting for an update rather than buying in and getting the largest return they can.
I know no one knows but do you have any perspective on what HEMO are waiting for and what could be holding up the update on financing?
I totally agree this is being manipulated. Sellers not allowing the price to rise ... I guess so they can continue to drive fud and concern about fund raising. At some point I guess news will be leaked or an RNS will arrive and people can then have guarantees that this is moving to the next level
Personally, I would rather buy at 3p then at 5p+ but I have learnt to be extremely patient (and less frustrated) with hemo and timelines.
HH told us sellers running on fumes and this has reached the bottom. This is surely the best time to load up at the bottom before the news on funds hits the street (I am expecting this week for an update !!!) and then 5p 1st uplift.
Yep and we know the reasons why ... lack of buyers, shorters, vlad's previous mess ups, uncertainty on funding etc etc
Until all that gets cleared up retail investors have no chance for a rerate. Once institutions come, we can all rejoice and screw the traders who control this stock
Hey Mickey ... Sorry if I could promise a rerate, I would be a millionaire and nostradamus's cousin but I cannot.
All I am going by is the number of shorts that are open, the massive sellers that have been selling for weeks since FDA announcement, prevail's investment at 6p and the brilliant comparisons that JHFH has posted on twitter showing we should be compared to $100m to $300m mcaps.
I don't control the market or buyers but like you have been here a long time and after reading Haywain's fabulous scientific updates, I now treat this opportunity has gamechanging like if u bought Tesla or Amazon at the beginning. It all has risk and at present it is being manipulated and too many doubters are worrying about funding issues (which I feel are totally being overblown) but all we can do is wait or sell. Yes we all frustrated as here to support a cancer breakthrough company and become millionaires ourselves and one day we hopefully will !!!
I am just stating we need buying volume vrs sellers thats all ... I dont invest in Avacta but well done to those who do I guess.
These 5% days are few with hemo and we all continue to wait for this so called rerate thats been coming for months / years
Dhub ...This daily analysis is totally useless unless you are trading the stock as its only applicable at that time
Haywain has outlined the science. JHFH and HH have outlined their analysis on next steps and why the market WILL RERATE but the facts are this will not get to realistic MCAP levels until we get 100% clarity on funding / JV / partnerships. Sadly all the excitement of the FDA approval is now distant as the sellers and traders control this stock again. Everytime there is a hint of recovery, there is an equal number of shares to drive it down. This is a coordinated attack on HEMO to drive confidence down and create more sells.
Its been 2 weeks and as always the great hype of HEMO is followed by silence and sells and people's lack of confidence in vlad. Another weekend and no news .. lets hope next week is the RERATE we keep being promised !!!!